Literature DB >> 6136901

The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.

M Waelbroeck, G Taton, M Delhaye, P Chatelain, J C Camus, R Pochet, J L Leclerc, J M De Smet, P Robberecht, J Christophe.   

Abstract

The beta-adrenergic stimulation of adenylate cyclase in membranes from human auricles, ventricles, and fetal heart was compared with the binding properties of beta-adrenergic receptors in human auricles. In terms of adenylate cyclase activation, three full agonists (isoproterenol, epinephrine, and norepinephrine), four partial agonists (procaterol, salbutamol, fenoterol, and zinterol), and four antagonists (propranolol, metoprolol, atenolol, and practolol) were tested. The beta-adrenergic activation of adenylate cyclase in membranes from rat heart (with a majority of beta 1-adrenergic receptors), rat erythrocytes, and rat reticulocytes (with a homogeneous population of beta 2-adrenergic receptors) served as reference. The reactivity of human heart adenylate cyclase, estimated by the Kact or Ki values of 11 beta-adrenergic agents, indicated that the activation of this enzyme occurred through receptors of the beta 2-subtype only. Receptors of the beta 1-subtype (50% of the total population) were not coupled to the enzyme.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136901

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.

Authors:  D Bojanic; J D Jansen; S R Nahorski; J Zaagsma
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

2.  Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.

Authors:  T Lherm; G Troché; M Rossignol; P Bordes; J F Zazzo
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

3.  Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors.

Authors:  F O Levy; X Zhu; A J Kaumann; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

4.  Studies on the intrinsic activity (efficacy) of human adrenergic receptors. Co-expression of beta 1 and beta 2 reveals a lower efficacy for the beta 1 receptor.

Authors:  L Birnbaumer; F O Levy; X Zhu; A J Kaumann
Journal:  Tex Heart Inst J       Date:  1994

5.  Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

Authors:  A Wellstein; D Palm; H F Pitschner; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium.

Authors:  A Mügge; D Posselt; U Reimer; W Schmitz; H Scholz
Journal:  Klin Wochenschr       Date:  1985-01-02

7.  Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

8.  The role of cyclic AMP in the positive inotropic effect mediated by beta 1- and beta 2-adrenoceptors in isolated human right atrium.

Authors:  K Ikezono; M C Michel; H R Zerkowski; J J Beckeringh; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

9.  Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.

Authors:  Jonas Jurevicius; V Arvydas Skeberdis; Rodolphe Fischmeister
Journal:  J Physiol       Date:  2003-06-18       Impact factor: 5.182

10.  Pharmacology and inotropic potential of forskolin in the human heart.

Authors:  M R Bristow; R Ginsburg; A Strosberg; W Montgomery; W Minobe
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.